Document Detail


The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum.
MedLine Citation:
PMID:  19864183     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The evolution of resistance in Plasmodium falciparum against safe and affordable drugs such as chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) is a major global health threat. Investigating the dynamics of resistance against these antimalarial drugs will lead to approaches for addressing the problem of resistance in malarial parasites that are solidly based in evolutionary genetics and population biology. In this article, we discuss current developments in population biology modeling and evolutionary genetics. Despite great advancements achieved in the past decade, understanding the complex dynamics of mutations conferring drug resistance in P. falciparum requires approaches that consider the parasite population structure among other demographic processes.
Authors:
Ananias A Escalante; David L Smith; Yuseob Kim
Related Documents :
6351863 - Rapid action of qinghaosu and related drugs on incorporation of [3h]isoleucine by plasm...
17610603 - The prevalence of dientamoeba fragilis in patients with suspected enteroparasitic disea...
19075663 - Application of drug repositioning strategy to tofisopam.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review     Date:  2009-10-26
Journal Detail:
Title:  Trends in parasitology     Volume:  25     ISSN:  1471-5007     ISO Abbreviation:  Trends Parasitol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-16     Completed Date:  2010-02-23     Revised Date:  2011-05-25    
Medline Journal Info:
Nlm Unique ID:  100966034     Medline TA:  Trends Parasitol     Country:  England    
Other Details:
Languages:  eng     Pagination:  557-63     Citation Subset:  IM    
Affiliation:
School of Life Sciences, Arizona State University, PO Box 874501, Tempe, AZ 85287-4501, USA. Ananias.Escalante@asu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antimalarials / pharmacology*,  therapeutic use
Drug Resistance / genetics*
Geography
Humans
Malaria, Falciparum / drug therapy,  transmission
Models, Biological
Mutation / genetics*
Plasmodium falciparum / drug effects*,  genetics*
Grant Support
ID/Acronym/Agency:
R01 GM084320-02/GM/NIGMS NIH HHS; R01GM084320/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Antimalarials

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Innate immune responses to influenza A H5N1: friend or foe?
Next Document:  Developing discharge practice through education Module development, delivery and outcomes.